These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 10365240

  • 1. [Use of nitric oxide in the evaluation of pulmonary arterial hypertension].
    García y Otero A, Cisneros Martínez O, García Germán F, Frutos Rangel E, Uribe Navarro J, Cárdenas López F.
    Arch Inst Cardiol Mex; 1998; 68(5):426-30. PubMed ID: 10365240
    [Abstract] [Full Text] [Related]

  • 2. Long-term outcome of patients operated for large ventricular septal defects with increased pulmonary vascular resistance.
    Kannan BR, Sivasankaran S, Tharakan JA, Titus T, Ajith Kumar VK, Francis B, Krishnamoorthy KM, Harikrishnan S, Padmakumar R, Nair K.
    Indian Heart J; 2003; 55(2):161-6. PubMed ID: 12921332
    [Abstract] [Full Text] [Related]

  • 3. Pulmonary vascular reactivity and prognosis in patients with chronic thromboembolic pulmonary hypertension: a pilot study.
    Skoro-Sajer N, Hack N, Sadushi-Koliçi R, Bonderman D, Jakowitsch J, Klepetko W, Hoda MA, Kneussl MP, Fedullo P, Lang IM.
    Circulation; 2009 Jan 20; 119(2):298-305. PubMed ID: 19118254
    [Abstract] [Full Text] [Related]

  • 4. Plasma levels of nitric oxide in children with congenital heart disease and increased pulmonary blood flow.
    Kiettisanpipop P, Lertsapcharorn P, Chotivittayatarakorn P, Poovorawan Y.
    J Med Assoc Thai; 2007 Oct 20; 90(10):2053-7. PubMed ID: 18041423
    [Abstract] [Full Text] [Related]

  • 5. Inhaled nitric oxide through a noninvasive ventilation device to assess reversibility of pulmonary hypertension in selecting recipients for heart transplant.
    Fojón S, Fernández-González C, Sánchez-Andrade J, López-Pérez JM, Hermida LF, Rodríguez JA, Juffé A.
    Transplant Proc; 2005 Nov 20; 37(9):4028-30. PubMed ID: 16386617
    [Abstract] [Full Text] [Related]

  • 6. Acute vasodilator test in pulmonary arterial hypertension: evaluation of two response criteria.
    Costa EL, Jardim C, Bogossian HB, Amato MB, Carvalho CR, Souza R.
    Vascul Pharmacol; 2005 Sep 20; 43(3):143-7. PubMed ID: 16061423
    [Abstract] [Full Text] [Related]

  • 7. [Atrial septal defect and severe pulmonary hypertension in an adult who needed nitric oxide inhalation after repair].
    Imanaka K, Kotsuka Y, Takamoto S, Furuse A, Inoue K, Shirai T.
    Kyobu Geka; 1998 Mar 20; 51(5):403-5. PubMed ID: 9594501
    [Abstract] [Full Text] [Related]

  • 8. [Pulmonary hypertension: the role of nitric oxide in adults].
    Neidecker J.
    Rev Esp Anestesiol Reanim; 2001 Dec 20; 48(10):457-9. PubMed ID: 11792299
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nitric oxide level in children with pulmonary hypertension.
    Narin F, Narin N, Pasaoglu H, Uzüm K, Erdogan R.
    Indian J Physiol Pharmacol; 2000 Jul 20; 44(3):335-9. PubMed ID: 10941623
    [Abstract] [Full Text] [Related]

  • 12. Abnormal vascular tone in infants and children with lung hypoplasia: Findings from cardiac catheterization and the response to chronic therapy.
    Keller RL, Moore P, Teitel D, Hawgood S, McQuitty J, Fineman JR.
    Pediatr Crit Care Med; 2006 Nov 20; 7(6):589-94. PubMed ID: 17006391
    [Abstract] [Full Text] [Related]

  • 13. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
    Homma N, Morio Y, Takahashi H, Yamamoto A, Suzuki T, Sato K, Muramatsu M, Fukuchi Y.
    Respiration; 2006 Nov 20; 73(1):105-12. PubMed ID: 16432296
    [Abstract] [Full Text] [Related]

  • 14. Assessment of operability of congenital cardiac shunts with increased pulmonary vascular resistance.
    Viswanathan S, Kumar RK.
    Catheter Cardiovasc Interv; 2008 Apr 01; 71(5):665-70. PubMed ID: 18360864
    [Abstract] [Full Text] [Related]

  • 15. [Vasodilatator testing with nitric oxide (bronchial control treatment system--BCTS) in patients with pulmonary hypertension].
    Podolec P, Kaźnica-Wiatr M, Podolec Z, Krochin M, Wilkołek P, Przybyłowski P, Wierzbicki K, Sadowski J, Zmudka K, Tracz W.
    Przegl Lek; 2004 Apr 01; 61(6):737-42. PubMed ID: 15724676
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of pulmonary artery banding in the setting of ventricular septal defects and severely elevated pulmonary vascular resistance.
    Khan SA, Gelb BD, Nguyen KH.
    Congenit Heart Dis; 2006 Sep 01; 1(5):244-50. PubMed ID: 18377533
    [Abstract] [Full Text] [Related]

  • 17. Use of sildenafil to facilitate weaning from inhaled nitric oxide in children with pulmonary hypertension following surgery for congenital heart disease.
    Lee JE, Hillier SC, Knoderer CA.
    J Intensive Care Med; 2008 Sep 01; 23(5):329-34. PubMed ID: 18701525
    [Abstract] [Full Text] [Related]

  • 18. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.
    Zimpfer D, Zrunek P, Roethy W, Czerny M, Schima H, Huber L, Grimm M, Rajek A, Wolner E, Wieselthaler G.
    J Thorac Cardiovasc Surg; 2007 Mar 01; 133(3):689-95. PubMed ID: 17320566
    [Abstract] [Full Text] [Related]

  • 19. Plasma endothelin-1, homocysteine and serum nitric oxide values in patients with left-to-right shunt.
    Ozerol IH, Pac FA, Ozerol E, Ege E, Yologlu S, Temel I, Pac M.
    Indian Heart J; 2004 Mar 01; 56(6):653-7. PubMed ID: 15751522
    [Abstract] [Full Text] [Related]

  • 20. Combined administration of intravenous dipyridamole and inhaled nitric oxide to assess reversibility of pulmonary arterial hypertension in potential cardiac transplant recipients.
    Lepore JJ, Dec GW, Zapol WM, Bloch KD, Semigran MJ.
    J Heart Lung Transplant; 2005 Nov 01; 24(11):1950-6. PubMed ID: 16297803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.